The obesity epidemic pharmacological challenges

Stephen R. Bloom, Francis P. Kuhajda, Ismail Laher, Xavier Pi-Sunyer, Gabriele V. Ronnett, Tricia M M Tan, David S. Weigle

Research output: Contribution to journalArticlepeer-review

Abstract

Obesity, defined by a body mass index greater than 30kg/m2, claims an increasing number of lives every year, underscoring a dire need for effective therapeutic interventions. The origins of the obesity epidemic are complex, but commonly cited factors include the large quantities of calorie-rich food that are readily accessible in modern society; eating habits adapted to fast-paced lifestyles; low levels of physical activity; and genetic programs that have evolved, especially in populations prone to famine, to favor the storage of excess calories (i.e., the thrifty-gene theory). It is estimated that more than thirty percent of adults, and about fifteen percent of juveniles, are obese. These high rates have led to dramatic increases in diseases such as type 2 diabetes, cardiovascular and respiratory diseases, depression, and some forms of cancer.

Original languageEnglish (US)
Pages (from-to)82-98
Number of pages17
JournalMol Interv
Volume8
Issue number2
DOIs
StatePublished - Apr 1 2008

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacy

Fingerprint Dive into the research topics of 'The obesity epidemic pharmacological challenges'. Together they form a unique fingerprint.

Cite this